Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus placebo for chronic low back pain
NL-OMON32370Phase 3Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) comparing Duloxetine 60 mg once daily with Placebo (2 arms). Primary endpoint: Brief Pain Inventory 24-hour average pain score. Started Sep 2008; status: active, not recruiting.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NL-OMON32370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32370.